Les études cas–non cas : principe, méthodes, biais et interprétations
- 1 May 2018
- journal article
- research article
- Published by Elsevier BV in Therapies
- Vol. 73 (3), 247-255
- https://doi.org/10.1016/j.therap.2017.08.006
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?Drug Safety, 2013
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2011
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based TherapiesGastroenterology, 2011
- Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event ReportingDiabetes Care, 2011
- A potential competition bias in the detection of safety signals from spontaneous reporting databasesPharmacoepidemiology and Drug Safety, 2010
- A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confoundingBritish Journal of Clinical Pharmacology, 2008
- The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactionsPharmacoepidemiology and Drug Safety, 2005
- Rates of Spontaneous Reporting of Adverse Drug Reactions in FranceJAMA, 2002
- A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Temporal Patterns of NSAID Spontaneous Adverse Event ReportsDrug Safety, 2001